FDA ANSWER! Yuck! Hehehe
$Milestone Pharmaceuticals(MIST.US$ Milestone Pharmaceuticals Received An FDA Refusal To File Letter For The New Drug Application For Self-administered Etripamil Nasal Spray For Paroxysmal Supraventricular Tachycardia![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
